RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xlife Sciences Stock

Xlife Sciences EBIT 2025

Xlife Sciences EBIT

-9 M CHF

Ticker

XLS.SW

ISIN

CH0461929603

WKN

A2PK6Z

In 2025, Xlife Sciences's EBIT was -9 M CHF, a -7.19% increase from the -9.7 M CHF EBIT recorded in the previous year.

The Xlife Sciences EBIT history

YEAREBIT (undefined CHF)
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-

Xlife Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Xlife Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Xlife Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Xlife Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Xlife Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Xlife Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Xlife Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Xlife Sciences’s growth potential.

Xlife Sciences Revenue, EBIT and net profit per share

DateXlife Sciences RevenueXlife Sciences EBITXlife Sciences Net Income
2025e2.15 M undefined-9 M undefined-3.72 M undefined
2024e1.79 M undefined-9.7 M undefined-3.43 M undefined
2023988,400 undefined-20.27 M undefined14.88 M undefined
20221.03 M undefined-20.97 M undefined14.31 M undefined
2021806,100 undefined-5.23 M undefined53.42 M undefined
2020396,800 undefined-3.09 M undefined21.46 M undefined
2019514,800 undefined-767,600 undefined1.05 M undefined

Xlife Sciences stock margins

The Xlife Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Xlife Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Xlife Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Xlife Sciences's sales revenue. A higher gross margin percentage indicates that the Xlife Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Xlife Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Xlife Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Xlife Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Xlife Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Xlife Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Xlife Sciences Margin History

Xlife Sciences Gross marginXlife Sciences Profit marginXlife Sciences EBIT marginXlife Sciences Profit margin
2025e45.43 %-419.77 %-173.52 %
2024e45.43 %-543.53 %-192.27 %
202345.43 %-2,050.7 %1,505.39 %
202218.05 %-2,039.42 %1,392.22 %
202144.55 %-648.94 %6,626.78 %
2020-6.45 %-778.38 %5,408.54 %
201934.77 %-149.11 %204 %

Xlife Sciences Aktienanalyse

What does Xlife Sciences do?

Xlife Sciences AG is a company active in the field of biotechnology. The company was founded in 2017 and is based in Switzerland. The main activity of Xlife Sciences AG is the identification and development of biotechnology products, particularly in the field of health sciences. The business model of Xlife Sciences AG is based on collaborations with leading scientists and research groups worldwide. The company identifies promising research areas and takes on the financing and development of projects until they are marketable. Xlife Sciences AG works closely with academic environments, universities, research institutes, venture capital firms, and other partners. Xlife Sciences AG specializes in three main divisions: Human Health, Agrifood, and Industrial Biotechnology. Under the Human Health division, the company develops drugs and therapies for various diseases and health problems. These include cancer, diabetes, cardiovascular diseases, infectious diseases, and autoimmune diseases. The Agrifood division of Xlife Sciences AG works on innovative solutions for agriculture and food production. This includes the development of plants that are resistant to pests and drought, as well as the development of foods with functional properties such as increased nutritional value or improved durability. The Industrial Biotechnology division of Xlife Sciences AG focuses on the development of biotechnological products for industrial use. This includes biofuels made from renewable raw materials and the production of biobased materials such as plastics and textiles. An example of a product developed by Xlife Sciences AG is a new drug against cancer. This drug was developed in collaboration with the University of Basel and has the potential to revolutionize cancer treatment. The effectiveness of the drug has already been proven in animal tests, and preparations for clinical trials are underway. Overall, Xlife Sciences AG aims to develop innovative technologies and products that improve people's lives while also being economically successful. The company relies on close cooperation with scientists, investors, and industry partners. Xlife Sciences AG has established itself as an important player in the biotechnology industry and continuously works to expand its range of products and services. Although the company is relatively young, it already has numerous promising projects in the pipeline and strives to develop innovative solutions for the challenges of our time in the future. Xlife Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Xlife Sciences's EBIT

Xlife Sciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Xlife Sciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Xlife Sciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Xlife Sciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Xlife Sciences stock

How much did Xlife Sciences achieve in EBIT for the current year?

In the current year, Xlife Sciences has achieved an EBIT of -9 M CHF.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Xlife Sciences.

How has the EBIT of Xlife Sciences developed in recent years?

The EBIT of Xlife Sciences has increased by -7.193% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Xlife Sciences?

The EBIT of Xlife Sciences is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Xlife Sciences pay?

Over the past 12 months, Xlife Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xlife Sciences is expected to pay a dividend of 0 CHF.

What is the dividend yield of Xlife Sciences?

The current dividend yield of Xlife Sciences is .

When does Xlife Sciences pay dividends?

Xlife Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xlife Sciences?

Xlife Sciences paid dividends every year for the past 0 years.

What is the dividend of Xlife Sciences?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xlife Sciences located?

Xlife Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xlife Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xlife Sciences from 3/5/2025 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 3/5/2025.

When did Xlife Sciences pay the last dividend?

The last dividend was paid out on 3/5/2025.

What was the dividend of Xlife Sciences in the year 2024?

In the year 2024, Xlife Sciences distributed 0 CHF as dividends.

In which currency does Xlife Sciences pay out the dividend?

The dividends of Xlife Sciences are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xlife Sciences

Our stock analysis for Xlife Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xlife Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.